• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症临床试验中健康相关生活质量的纵向分析:方法和结果解读。

Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.

机构信息

Biometrics Unit - CTD INCa, Institut du Cancer Montpellier, Univ. Montpellier, Montpellier, France.

Institut de Recherche en Cancérologie de Montpellier Inserm U1194, University Montpellier, 208 rue des Apothicaire, Montpellier Cedex 5, 34298, Montpellier, France.

出版信息

Qual Life Res. 2021 Jan;30(1):91-103. doi: 10.1007/s11136-020-02605-3. Epub 2020 Aug 18.

DOI:10.1007/s11136-020-02605-3
PMID:32809099
Abstract

PURPOSE

Health-related quality of life (HRQoL) is assessed by self-administered questionnaires throughout the care process. Classically, two longitudinal statistical approaches were mainly used to study HRQoL: linear mixed models (LMM) or time-to-event models for time to deterioration/time until definitive deterioration (TTD/TUDD). Recently, an alternative strategy based on generalized linear mixed models for categorical data has also been proposed: the longitudinal partial credit model (LPCM). The objective of this article is to evaluate these methods and to propose recommendations to standardize longitudinal analysis of HRQoL data in cancer clinical trials.

METHODS

The three methods are first described and compared through statistical, methodological, and practical arguments, then applied on real HRQoL data from clinical cancer trials or published prospective databases. In total, seven French studies from a collaborating group were selected with longitudinal collection of QLQ-C30. Longitudinal analyses were performed with the three approaches using SAS, Stata and R software.

RESULTS

We observed concordant results between LMM and LPCM. However, discordant results were observed when we considered the TTD/TUDD approach compared to the two previous methods. According to methodological and practical arguments discussed, the approaches seem to provide additional information and complementary interpretations. LMM and LPCM are the most powerful methods on simulated data, while the TTD/TUDD approach gives more clinically understandable results. Finally, for single-item scales, LPCM is more appropriate.

CONCLUSION

These results pledge for the recommendation to use of both the LMM and TTD/TUDD longitudinal methods, except for single-item scales, establishing them as the consensual methods for publications reporting HRQoL.

摘要

目的

健康相关生活质量(HRQoL)是通过自我管理问卷在整个治疗过程中进行评估的。传统上,主要使用两种纵向统计方法来研究 HRQoL:线性混合模型(LMM)或用于恶化时间/直到明确恶化时间(TTD/TUDD)的时间事件模型。最近,还提出了一种基于分类数据广义线性混合模型的替代策略:纵向部分信用模型(LPCM)。本文的目的是评估这些方法,并提出建议,以标准化癌症临床试验中 HRQoL 数据的纵向分析。

方法

首先通过统计、方法和实际论据描述和比较这三种方法,然后应用于来自癌症临床试验或已发表前瞻性数据库的真实 HRQoL 数据。共选择了来自协作组的七个法国研究,对 QLQ-C30 进行纵向收集。使用 SAS、Stata 和 R 软件,通过三种方法进行纵向分析。

结果

我们观察到 LMM 和 LPCM 之间的结果一致。然而,当我们将 TTD/TUDD 方法与前两种方法进行比较时,观察到了不一致的结果。根据讨论的方法和实际论据,这些方法似乎提供了额外的信息和补充解释。在模拟数据中,LMM 和 LPCM 是最强大的方法,而 TTD/TUDD 方法则提供了更具临床意义的结果。最后,对于单项量表,LPCM 更适用。

结论

这些结果支持使用 LMM 和 TTD/TUDD 纵向方法的建议,除了单项量表,将它们确立为报告 HRQoL 的共识方法。

相似文献

1
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.癌症临床试验中健康相关生活质量的纵向分析:方法和结果解读。
Qual Life Res. 2021 Jan;30(1):91-103. doi: 10.1007/s11136-020-02605-3. Epub 2020 Aug 18.
2
Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.肿瘤学中三种纵向分析模型对健康相关生活质量的比较:一项模拟研究
Health Qual Life Outcomes. 2014 Dec 31;12:192. doi: 10.1186/s12955-014-0192-2.
3
Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD.时间依赖性事件方法在肿瘤学中的纵向健康相关生活质量分析,STATA 命令 qlqc30_TTD。
Comput Methods Programs Biomed. 2018 May;158:153-159. doi: 10.1016/j.cmpb.2018.02.010. Epub 2018 Feb 17.
4
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial.应用项目反应理论中的纵向模型评估PRODIGE 4/ACCORD 11随机试验中与健康相关的生活质量。
Med Decis Making. 2016 Jul;36(5):615-28. doi: 10.1177/0272989X15621883. Epub 2015 Dec 18.
5
Item response models for the longitudinal analysis of health-related quality of life in cancer clinical trials.用于癌症临床试验中健康相关生活质量纵向分析的项目反应模型。
BMC Med Res Methodol. 2017 Sep 26;17(1):148. doi: 10.1186/s12874-017-0410-9.
6
Time to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?作为肿瘤学中健康相关生活质量研究纵向分析方式的健康相关生活质量评分恶化时间:我们是否需要实体瘤疗效评价标准来实现生活质量的标准化?
Qual Life Res. 2015 Jan;24(1):5-18. doi: 10.1007/s11136-013-0583-6. Epub 2013 Nov 26.
7
Time to Definitive Health-Related Quality of Life Score Deterioration in Patients with Resectable Metastatic Colorectal Cancer Treated with FOLFOX4 versus Sequential Dose-Dense FOLFOX7 followed by FOLFIRI: The MIROX Randomized Phase III Trial.接受FOLFOX4与序贯剂量密集型FOLFOX7后再用FOLFIRI治疗的可切除转移性结直肠癌患者达到明确的健康相关生活质量评分恶化的时间:MIROX随机III期试验
PLoS One. 2016 Jun 16;11(6):e0157067. doi: 10.1371/journal.pone.0157067. eCollection 2016.
8
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.处理健康相关生活质量纵向分析中的信息缺失:从食管癌临床试验 PRODIGE 5/ACCORD 17 数据中应用三种方法。
BMC Med Res Methodol. 2020 Sep 3;20(1):223. doi: 10.1186/s12874-020-01104-w.
9
%TTD and %TUDD: New SAS macro programs to calculate the survival data of the time to deterioration for patient-reported outcomes data in oncology.%TTD 和 %TUDD:新的 SAS 宏程序,用于计算肿瘤患者报告结局数据恶化时间的生存数据。
Comput Methods Programs Biomed. 2022 Feb;214:106537. doi: 10.1016/j.cmpb.2021.106537. Epub 2021 Nov 21.
10
Effect of Regorafenib in Delaying Definitive Deterioration in Health-Related Quality of Life in Patients with Advanced Cancer of Three Different Tumor Types.瑞戈非尼对三种不同肿瘤类型的晚期癌症患者健康相关生活质量明确恶化的延迟作用。
Cancer Manag Res. 2021 Jul 12;13:5523-5533. doi: 10.2147/CMAR.S305939. eCollection 2021.

引用本文的文献

1
Patient-Reported Functional Outcomes and Quality of Life After Contact X-Ray Brachytherapy (CXB) in Organ-Preserving Management of Rectal Cancer.直肠癌保器官治疗中接触X线近距离放疗(CXB)后患者报告的功能结局和生活质量
Cancers (Basel). 2025 May 3;17(9):1560. doi: 10.3390/cancers17091560.
2
Impact of adapted physical activity and diet counselling on health-related quality of life in women undergoing adjuvant breast cancer therapy.适应性体育活动和饮食咨询对接受辅助性乳腺癌治疗的女性健康相关生活质量的影响。
Sci Rep. 2025 Mar 10;15(1):8215. doi: 10.1038/s41598-025-91569-w.
3
Time to deterioration of patient-reported outcome endpoints in cancer clinical trials: targeted literature review and best practice recommendations.
癌症临床试验中患者报告结局终点的恶化时间:针对性文献综述与最佳实践建议
J Patient Rep Outcomes. 2024 Dec 18;8(1):150. doi: 10.1186/s41687-024-00824-7.
4
Assessing tilavonemab efficacy in early Alzheimer's disease via longitudinal item response theory modeling.通过纵向项目反应理论建模评估替拉沃单抗在早期阿尔茨海默病中的疗效。
Alzheimers Dement (N Y). 2024 Jun 4;10(2):e12471. doi: 10.1002/trc2.12471. eCollection 2024 Apr-Jun.
5
Improvement of postoperative quality of life in patients with esophageal squamous cell carcinoma: does tea consumption have a role?提高食管鳞癌患者术后生活质量:饮茶是否有作用?
BMC Public Health. 2022 Nov 24;22(1):2165. doi: 10.1186/s12889-022-14646-z.
6
Application of longitudinal item response theory models to modeling Parkinson's disease progression.纵向项目反应理论模型在帕金森病进展建模中的应用。
CPT Pharmacometrics Syst Pharmacol. 2022 Oct;11(10):1382-1392. doi: 10.1002/psp4.12853. Epub 2022 Aug 9.
7
Dissecting the Domains of Parkinson's Disease: Insights from Longitudinal Item Response Theory Modeling.剖析帕金森病的领域:来自纵向项目反应理论建模的见解。
Mov Disord. 2022 Sep;37(9):1904-1914. doi: 10.1002/mds.29154. Epub 2022 Jul 16.
8
Utility values and its time to deterioration in breast cancer patients after diagnosis and during treatments.诊断后和治疗期间乳腺癌患者的效用值及其恶化时间。
Qual Life Res. 2022 Oct;31(10):3077-3085. doi: 10.1007/s11136-022-03157-4. Epub 2022 May 19.